好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Exploring Sex Differences in the Degeneration of the Nucleus Basalis of Meynert and its White Matter Tracts in Neurodegenerative Diseases
Aging, Dementia, and Behavioral Neurology
P10 - Poster Session 10 (5:00 PM-6:00 PM)
3-017

Determine the structural integrity of the Nucleus Basalis of Meynert(NBM), and its projections, in people in different stages of Alzheimer's Disease, Parkinson's Disease, and Lewy Body Dementia, and explore the effect of sex differences on NBM degeneration, within each of these groups. This was also determined in age-matched healthy controls

Recent research has demonstrated that degeneration of the cholinergic network could be partially responsible for the decline in cognitive function found in Alzheimer's Disease (AD), Lewy Body Dementia (DLB), and Parkinson’s Disease (PD). Some aspects of cognitive functioning that have been shown to be affected are attention, visuospatial processing, and arousal. Research also demonstrates that sex can factor into which neurodegenerative disease someone will get, but there are not many studies specifically focused on sex differences in NBM atrophy. 

We have collated data from 250 participants from two databases: Parkinson’s Progression Markers Initiative and the Alzheimer’s Disease Neuroimaging Initiative: 50 ADNI healthy controls (HC), 50 AD-Mild Cognitive Impairment (AD-MCI), 50 AD, 34 PPMI HCs, PD-no MCI, and 50 PD-MCI. Both databases included structural MRIs and neuropsychological batteries. We assessed gray matter volume of the NBM from the T1 image across each of these groups using voxel-based morphometry. For the tract analysis, we extracted the mean diffusivity of the lateral and medial NBM tracts using diffusion tensor imaging. 

There was a significant difference in degeneration between the male and female cohorts, with the male cohort having significantly more deterioration in the NBM, as well as both of its tracts, in both AD and PD, but not healthy controls.  

 

This study will characterize the degeneration of the cortical cholinergic system across a spectrum of neurodegenerative diseases, and the mechanisms behind the atrophy which may be affected by sex-related differences. This could possibly lead to more targeted therapies in the future. 
Authors/Disclosures
Tatianna M. Howard, Research Assistant
PRESENTER
Ms. Howard has nothing to disclose.
Charlotte Casselton, Research Assistant Miss Casselton has nothing to disclose.
Gang Seo, PhD Dr. Seo has nothing to disclose.
Annie Abay Miss Abay has nothing to disclose.
Kevin Wilkins, PhD Dr. Wilkins has nothing to disclose.
Rachel Crockett, PhD Dr. Crockett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VerityXR.